# Z-DNA Found in Biology: Location, Function, and Detection

## Introduction to Z-DNA

Deoxyribonucleic acid (DNA) is most commonly depicted as a right-handed double helix, the B-form, which was first described by Watson and Crick in 1953. However, DNA is conformationally polymorphic. Under specific conditions, it can adopt alternative structures, including A-DNA, cruciforms, triplexes, and left-handed Z-DNA. Z-DNA is a left-handed double helix in which the sugar-phosphate backbone follows a zigzag path, giving the molecule its name. This structural departure from B-DNA has profound implications for genome function, gene regulation, and disease.

### Discovery of Z-DNA

Z-DNA was discovered in 1979 by Alexander Rich and colleagues at the Massachusetts Institute of Technology. The team solved the X-ray crystal structure of a short DNA hexamer with the sequence d(CG)₃ and observed, unexpectedly, a left-handed helix. This was a landmark finding because it demonstrated that DNA is not a static molecule but can adopt radically different conformations depending on sequence and environment. The initial structure was solved using the synthetic polymer poly(dG-dC)·poly(dG-dC), which readily forms Z-DNA under high salt conditions. Subsequent work showed that Z-DNA can form in natural DNA sequences, particularly those with alternating purine-pyrimidine repeats.

### Structural features of Z-DNA

The Z-DNA helix is left-handed, meaning it twists in the opposite direction to B-DNA. Its most distinctive feature is the zigzag arrangement of the phosphodiester backbone, which results from alternating sugar pucker conformations: deoxyguanosine adopts a C3′-endo (north) pucker, while deoxycytidine adopts a C2′-endo (south) pucker. This alternation causes the repeating unit to be a dinucleotide, not a mononucleotide, so the helix has 12 base pairs per turn (compared to 10.5 in B-DNA) and a diameter of approximately 18 Å (compared to 20 Å for B-DNA). The major groove of Z-DNA is nearly flat, while the minor groove is deep and narrow. Importantly, the glycosidic bond conformation alternates between anti (for pyrimidines) and syn (for purines). This syn conformation is sterically favorable only for purines, which explains why alternating purine-pyrimidine sequences, especially d(GC)ₙ and d(GT)ₙ, most readily form Z-DNA. The [Base Pairing](/knowledge/molecular-biology/base-pairing) rules (G-C and A-T) are preserved in Z-DNA, but the geometry of the helix is entirely different.

## Where Z-DNA Is Found in the Genome

Z-DNA is not uniformly distributed across the genome. It forms transiently at specific loci, typically those with sequences that have a low energy barrier to the B-to-Z transition. Genomic mapping and biochemical studies have identified several regions where Z-DNA is preferentially found.

### Alternating purine-pyrimidine motifs

The most favorable sequences for Z-DNA formation are alternating purine-pyrimidine repeats, particularly d(CG)ₙ and d(CA)ₙ/d(TG)ₙ. These sequences have the lowest free energy cost for the B-to-Z transition. In the human genome, d(CA)ₙ repeats are abundant, occurring roughly once every 30,000 base pairs. However, not all such repeats adopt Z-DNA constitutively; formation depends on the local environment, including supercoiling and protein binding. Short runs of alternating pyrimidine-purine sequence (e.g., 6–12 bp) are sufficient to nucleate Z-DNA, especially when flanked by regions that can absorb the torsional strain of the transition.

### Promoters and enhancers

Z-DNA is frequently found in promoter regions of genes. A well-characterized example is the human c-MYC gene, where a Z-DNA-forming sequence is located upstream of the P1 promoter. This region, which contains an alternating purine-pyrimidine tract, has been shown to adopt Z-DNA in vitro under negative supercoiling and to influence promoter activity in vivo. Similarly, the rat somatostatin gene promoter contains a Z-DNA-forming element that responds to transcriptional activators. Enhancer regions, which bind regulatory proteins to increase transcription, also contain Z-DNA-forming sequences. The presence of Z-DNA in these regions suggests it plays a role in modulating access of [transcription factors](/knowledge/molecular-biology/transcription-factor) to their binding sites.

### Transcriptionally active regions

Z-DNA formation is tightly linked to transcription. As RNA polymerase translocates along the DNA template, it generates positive supercoiling ahead of the fork and negative supercoiling behind it. The negative supercoiling behind the polymerase is a strong driver of Z-DNA formation. Consequently, Z-DNA is found transiently in the wake of transcribing RNA polymerases, particularly in the promoter-proximal regions of actively transcribed genes. This phenomenon has been demonstrated using Z-DNA-specific antibodies in chromatin immunoprecipitation (ChIP) experiments, which show enrichment of Z-DNA at the 5′ ends of transcribed genes. The dynamic nature of this association means that Z-DNA is not a static structural feature but a transient regulatory signal that appears and disappears with transcriptional activity.

## Biological Functions of Z-DNA

The discovery of Z-DNA raised the question of whether it is a functional element or merely a structural curiosity. Over the past four decades, evidence has accumulated that Z-DNA participates in several biological processes, particularly transcription regulation, [chromatin remodeling](/knowledge/molecular-biology/chromatin-remodeling), and genome stability.

### Role in transcription

Z-DNA has been shown to regulate transcription in both positive and negative ways, depending on the gene and context. One well-studied mechanism involves the Z-DNA-binding protein ADAR1 (adenosine deaminase acting on RNA 1), which binds Z-DNA through its Zα domain. ADAR1 binding to Z-DNA in the promoter of the interferon-stimulated gene (ISG) family can enhance or repress transcription. For example, in the human c-MYC gene, Z-DNA formation in the promoter region is associated with transcriptional activation. The mechanism is thought to involve the relief of torsional stress: Z-DNA formation absorbs negative supercoiling, preventing the accumulation of excessive supercoiling that would otherwise stall RNA polymerase. In other contexts, Z-DNA can act as a roadblock, preventing [transcription factor](/knowledge/molecular-biology/transcription-factor) binding and thereby repressing gene expression. The net effect depends on the position of the Z-DNA-forming sequence relative to the transcription start site and the availability of Z-DNA-binding proteins.

### Z-DNA and [chromatin structure](/knowledge/molecular-biology/chromatin-structure)

Z-DNA formation influences chromatin architecture. The B-to-Z transition alters the helical twist and the positioning of nucleosomes. Because Z-DNA has a different helical repeat (12 bp/turn vs. 10.5 bp/turn), its formation can shift the rotational positioning of DNA on the nucleosome surface, affecting nucleosome stability and sliding. In vitro studies have shown that Z-DNA-forming sequences are poor substrates for nucleosome assembly, and that nucleosomes are destabilized when the underlying DNA adopts Z-conformation. This destabilization can expose regulatory elements to transcription factors and [chromatin remodelers](/knowledge/molecular-biology/chromatin-remodelers). Additionally, Z-DNA has been linked to the recruitment of chromatin-modifying enzymes. For instance, the chromatin remodeler ATRX (alpha thalassemia/mental retardation X-linked) contains a Z-DNA-binding domain and is recruited to Z-DNA-forming sequences at telomeres and pericentromeric heterochromatin, where it facilitates deposition of the histone variant H3.3. This connection between Z-DNA and [Chromatin Structure](/knowledge/molecular-biology/chromatin-structure) suggests a role in establishing and maintaining chromatin states.

### Z-DNA in disease

Z-DNA has been implicated in several human diseases. Perhaps the most direct link is to autoimmune diseases, where anti-Z-DNA antibodies are found in the serum of patients with systemic lupus erythematosus (SLE). These antibodies are distinct from anti-B-DNA antibodies and may contribute to the inflammatory pathology of the disease. Z-DNA has also been associated with cancer. The c-MYC and BCL-2 oncogenes contain Z-DNA-forming sequences in their regulatory regions, and the B-to-Z transition has been linked to chromosomal translocations and gene amplification. In addition, Z-DNA formation can promote genetic instability by causing DNA breaks. The Z-conformation is a poor substrate for DNA repair enzymes, and the junction between B-DNA and Z-DNA is a site of enhanced susceptibility to nuclease cleavage. This instability can lead to deletions, insertions, and translocations, which are hallmarks of cancer cells. Finally, Z-DNA has been implicated in neurological disorders, although the evidence is less well established.

## Conditions That Stabilize Z-DNA

The B-to-Z transition is energetically unfavorable under standard physiological conditions. However, several factors can lower the energy barrier and stabilize Z-DNA.

### High ionic strength

The Z-conformation is stabilized by high salt concentrations. In vitro, the B-to-Z transition of poly(dG-dC) occurs at NaCl concentrations above 2.5 M or at much lower concentrations of divalent cations such as Mg²⁺ (around 0.7 M). The mechanism is electrostatic: the Z-form has a more compact backbone with closer phosphate groups, and high ionic strength screens the electrostatic repulsion between these negatively charged phosphates. While such salt concentrations are not physiological, they demonstrate the intrinsic propensity of certain sequences to adopt Z-DNA and are used experimentally to induce Z-DNA formation in vitro.

### Negative supercoiling

The most physiologically relevant driver of Z-DNA formation is negative supercoiling. In living cells, DNA is underwound, meaning it has fewer helical turns than relaxed DNA. This underwinding generates torsional tension that can be relieved by local structural transitions, including strand separation, cruciform extrusion, and the B-to-Z transition. Because Z-DNA has a left-handed helix, its formation absorbs negative supercoiling: each base pair converted from B to Z removes approximately one negative superhelical turn. The free energy of negative supercoiling is sufficient to drive Z-DNA formation in sequences that would otherwise remain in B-form. This is why Z-DNA is found in the wake of transcribing RNA polymerases, where negative supercoiling is generated locally. The relationship between supercoiling and Z-DNA is discussed further in the context of [DNA Supercoiling](/knowledge/molecular-biology/dna-supercoiling).

### Chemical modifications

Chemical modifications to DNA bases can also stabilize Z-DNA. Methylation of cytosine at the C5 position, which occurs in CpG dinucleotides, promotes Z-DNA formation. This is significant because CpG methylation is a common epigenetic mark associated with gene silencing. The methyl group adds hydrophobic character to the major groove, which is shallow in Z-DNA, and stabilizes the Z-conformation. Other modifications, such as bromination of guanine at C8, also stabilize Z-DNA by favoring the syn conformation of the glycosidic bond. These chemical modifications provide a link between epigenetic marks and DNA structure, suggesting that methylation may act in part by promoting Z-DNA formation at specific loci.

## Proteins That Bind Z-DNA

The existence of Z-DNA in cells implies the existence of proteins that recognize and bind this structure. Several Z-DNA-binding proteins have been identified, and their functions reveal the biological significance of Z-DNA.

### ADAR1 and RNA editing

ADAR1 is the best-characterized Z-DNA-binding protein. It contains an N-terminal Zα domain that binds Z-DNA with high affinity (dissociation constant in the nanomolar range) and high specificity. ADAR1 is primarily known for its role in RNA editing: it deaminates adenosine to inosine in double-stranded RNA, a process that alters codons and splicing patterns. However, ADAR1 also binds Z-DNA in the nucleus, and this binding is important for its function in the interferon response. ADAR1 is induced by interferon, and its Zα domain is required for the regulation of certain interferon-stimulated genes. The current model is that ADAR1 binds to Z-DNA formed at the promoters of these genes, recruiting additional factors that modulate transcription. The Zα domain is also found in other proteins, including ZBP1 ([Z-DNA binding protein 1](/knowledge/molecular-biology/z-dna-binding-protein-1)) and the viral protein E3L from vaccinia virus, indicating that Z-DNA recognition is a conserved function.

### ZBP1 and innate immunity

ZBP1, also known as DAI (DNA-dependent activator of IFN-regulatory factors), is a cytosolic sensor of Z-DNA and Z-RNA. ZBP1 contains two Zα domains and, upon binding Z-form nucleic acids, activates the innate immune response. It triggers the NF-κB pathway and the production of type I interferons, which are critical for antiviral defense. ZBP1 has also been implicated in necroptosis, a form of programmed cell death, through its interaction with RIPK3 (receptor-interacting protein kinase 3). The discovery that ZBP1 senses Z-DNA suggests that Z-DNA or Z-RNA produced during viral infection serves as a danger signal that alerts the immune system. This places Z-DNA at the interface of nucleic acid structure and innate immunity.

## Methods to Detect and Study Z-DNA

Detecting Z-DNA in biological samples requires methods that can distinguish it from B-DNA. Several approaches have been developed, each with specific advantages and limitations.

### Z-DNA specific antibodies

The most widely used method for detecting Z-DNA is immunodetection with Z-DNA-specific antibodies. These antibodies, such as the monoclonal antibody Z22, recognize the Z-conformation with high specificity and do not cross-react with B-DNA. They can be used in several applications:

1. **[Immunofluorescence microscopy](/blog/guides/immunofluorescence-microscopy-controls-for-specific-and-reproducible-images)**: Cells are fixed, permeabilized, and stained with anti-Z-DNA antibodies. This allows visualization of Z-DNA in situ and its subcellular localization.
2. **Chromatin immunoprecipitation (ChIP)**: Cells are cross-linked with formaldehyde, chromatin is sheared, and Z-DNA-containing fragments are immunoprecipitated with anti-Z-DNA antibodies. The associated DNA is then identified by PCR or sequencing. This method has been used to map Z-DNA sites across the genome.
3. **Enzyme-linked immunosorbent assay (ELISA)**: Purified DNA or nucleoprotein complexes are immobilized on a plate and probed with anti-Z-DNA antibodies to quantify Z-DNA content.

A key limitation of antibody-based methods is that they require fixation, which may not preserve the native Z-DNA conformation. Additionally, the binding of the antibody itself can stabilize Z-DNA, potentially overestimating its abundance.

### Circular dichroism spectroscopy

Circular dichroism (CD) spectroscopy is a biophysical technique that measures the differential absorption of left- and right-circularly polarized light by chiral molecules. B-DNA and Z-DNA have distinct CD spectra: B-DNA shows a positive band around 275 nm and a negative band around 245 nm, while Z-DNA shows a negative band around 290 nm and a positive band around 260 nm (for poly(dG-dC)). The transition from B to Z is easily monitored by the inversion of the CD signal. CD spectroscopy is used primarily for in vitro studies of Z-DNA formation under controlled conditions (e.g., varying salt concentration or supercoiling). It is not suitable for detecting Z-DNA in living cells but is invaluable for characterizing the thermodynamics and kinetics of the B-to-Z transition.

### Chemical footprinting

Chemical probes that react preferentially with Z-DNA can be used to detect Z-DNA in vitro and in vivo. One such probe is osmium tetroxide, which reacts with pyrimidines in single-stranded or distorted DNA regions, including the B-Z junction. Another is diethyl pyrocarbonate (DEPC), which reacts with purines in the syn conformation, a hallmark of Z-DNA. After treatment with the probe, DNA is cleaved at the modified bases, and the cleavage pattern is analyzed by gel electrophoresis. This method provides single-nucleotide resolution of Z-DNA boundaries. However, chemical footprinting requires purified DNA or isolated nuclei and is technically demanding.

## Z-DNA in Disease and Therapeutics

The involvement of Z-DNA in disease processes has made it a potential target for therapeutic intervention.

### Z-DNA and cancer

Z-DNA-forming sequences are enriched in the regulatory regions of oncogenes and [tumor suppressor genes](/knowledge/molecular-biology/tumor-suppressor-gene). The c-MYC gene, which is frequently amplified or translocated in cancer, contains a Z-DNA-forming sequence in its promoter. The B-to-Z transition at this locus is associated with increased transcriptional activity and genomic instability. Similarly, the BCL-2 gene, which is overexpressed in many lymphomas, has a Z-DNA-forming element in its 5′ untranslated region. Z-DNA formation at these loci can promote chromosomal breaks, leading to translocations that drive tumorigenesis. In addition, the presence of Z-DNA can affect the binding of transcription factors and repair proteins, contributing to the altered gene expression patterns seen in cancer cells. Targeting Z-DNA or the proteins that bind it is an emerging therapeutic strategy. Small molecules that stabilize B-DNA and prevent the B-to-Z transition, or that bind specifically to Z-DNA and block its function, are being explored as anticancer agents.

### Z-DNA in autoimmunity

Anti-Z-DNA antibodies are found in the serum of patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. These antibodies are produced when Z-DNA is released from dying cells and presented to the immune system. The presence of anti-Z-DNA antibodies correlates with disease activity in some patients, suggesting they may contribute to pathology. The mechanism is thought to involve the formation of immune complexes that deposit in tissues, particularly the kidneys, leading to inflammation and tissue damage. Understanding how Z-DNA is generated and released during cell death may lead to new therapeutic approaches for autoimmune diseases, such as inhibiting the enzymes that produce Z-DNA or blocking the immune response to Z-DNA.

### Therapeutic implications

The unique structure of Z-DNA offers opportunities for therapeutic intervention. One approach is to use Z-DNA-binding proteins as delivery vehicles for targeted therapy. For example, the Zα domain of ADAR1 could be fused to a therapeutic protein or a cytotoxic agent to deliver it specifically to Z-DNA-containing regions of the genome. Another approach is to develop small molecules that modulate the B-to-Z transition. Such molecules could be used to alter gene expression at specific loci, either by promoting Z-DNA formation to repress an oncogene or by preventing Z-DNA formation to activate a tumor suppressor. Finally, Z-DNA itself could be used as a vaccine adjuvant, as it stimulates the innate immune response through ZBP1. These therapeutic avenues are still in early stages, but they highlight the potential of Z-DNA as a target for drug development.

## Common Misconceptions and Pitfalls

Students often encounter several misconceptions when learning about Z-DNA. Clarifying these points is essential for a correct understanding.

### Z-DNA is not an artifact

A common misconception is that Z-DNA is an in vitro artifact that does not exist in living cells. This is incorrect. Z-DNA has been detected in vivo using Z-DNA-specific antibodies, and its formation is driven by physiological processes such as transcription. The transient and localized nature of Z-DNA makes it difficult to detect, but its existence in cells is well established. The fact that Z-DNA-binding proteins (ADAR1, ZBP1) have evolved specifically to recognize this structure is strong evidence that Z-DNA is functionally relevant in vivo.

### Z-DNA is not always harmful

Another misconception is that Z-DNA is a pathological structure that causes disease. While Z-DNA has been linked to cancer and autoimmunity, it also has normal biological functions, particularly in transcription regulation and the innate immune response. Z-DNA formation is a regulated process that is part of the cell's normal repertoire of DNA structures. The harmful effects of Z-DNA arise when its formation is dysregulated, for example, when it occurs at the wrong place or time, or when it is not properly resolved by Z-DNA-binding proteins.

### Distinguishing Z-DNA from other non-B DNA

Students sometimes confuse Z-DNA with other non-B DNA structures, such as cruciforms, triplexes, or G-quadruplexes. These structures are distinct: cruciforms are four-way junctions formed by inverted repeats; triplexes are three-stranded structures formed by Hoogsteen base pairing; G-quadruplexes are four-stranded structures formed by guanine-rich sequences. Z-DNA is a left-handed duplex, and it is the only non-B DNA structure that is a true double helix. The conditions that favor each structure also differ: Z-DNA is favored by negative supercoiling and high salt, while G-quadruplexes are favored by potassium ions and single-stranded DNA. Understanding these distinctions is important for interpreting experimental results and for predicting where each structure might form in the genome.

## Summary and Study Tips

### Key takeaways

- Z-DNA is a left-handed double helix with a zigzag backbone, first discovered in 1979.
- Z-DNA forms preferentially at alternating purine-pyrimidine sequences, especially d(CG)ₙ and d(CA)ₙ.
- Z-DNA is found in promoters, enhancers, and transcriptionally active regions of the genome.
- The primary biological function of Z-DNA is in transcription regulation, where it acts as a torsional stress reliever and a regulatory signal.
- Z-DNA is stabilized by high ionic strength, negative supercoiling, and cytosine methylation.
- Z-DNA-binding proteins, including ADAR1 and ZBP1, mediate the biological effects of Z-DNA.
- Z-DNA is detected using specific antibodies, circular dichroism spectroscopy, and chemical footprinting.
- Z-DNA is implicated in cancer, autoimmune diseases, and innate immunity.

### Exam-focused review

When studying Z-DNA for an exam, focus on the following points:

1. **Structural differences between B-DNA and Z-DNA**: Know the helical handedness, repeat unit, groove dimensions, and sugar pucker conformations.
2. **Sequence requirements**: Be able to identify a Z-DNA-forming sequence (alternating purine-pyrimidine).
3. **Conditions for formation**: Understand the roles of salt, supercoiling, and methylation.
4. **Biological functions**: Be able to explain how Z-DNA regulates transcription and how it is linked to disease.
5. **Detection methods**: Know the principle behind each method and its limitations.
6. **Key proteins**: Know the names and functions of ADAR1 and ZBP1.

A useful study strategy is to draw a diagram of B-DNA and Z-DNA side by side, labeling the key structural features. Another is to create a table comparing the properties of B-DNA and Z-DNA, including helical handedness, diameter, base pairs per turn, and groove characteristics. Practice explaining the B-to-Z transition in terms of supercoiling and torsional stress, as this is a common exam question.

## Frequently Asked Questions

### Where is Z-DNA found in the genome?

Z-DNA is found at specific genomic locations, primarily in regions with alternating purine-pyrimidine sequences. These include promoters, enhancers, and transcriptionally active regions. In the human genome, Z-DNA-forming sequences are enriched near genes, particularly at the 5′ ends, where transcription generates the negative supercoiling needed to drive Z-DNA formation.

### Is Z-DNA found in living cells?

Yes, Z-DNA is found in living cells. It was initially detected using Z-DNA-specific antibodies, and subsequent studies using chromatin immunoprecipitation and other methods have confirmed its presence in vivo. Z-DNA is transient and localized, forming in response to transcriptional activity and other processes that generate negative supercoiling.

### What conditions favor Z-DNA formation?

Z-DNA formation is favored by high ionic strength (e.g., >2.5 M NaCl for poly(dG-dC)), negative supercoiling, and chemical modifications such as cytosine methylation. In cells, negative supercoiling generated by transcription is the primary driver of Z-DNA formation.

### What is the function of Z-DNA?

Z-DNA has several proposed functions, including regulation of transcription, modulation of chromatin structure, and participation in the innate immune response. It acts as a torsional stress reliever during transcription and serves as a binding site for proteins such as ADAR1 and ZBP1.

### How is Z-DNA detected experimentally?

Z-DNA is detected using Z-DNA-specific antibodies (immunofluorescence, ChIP, ELISA), circular dichroism spectroscopy (which distinguishes B- and Z-DNA by their characteristic spectra), and chemical footprinting with probes that react preferentially with Z-DNA.

### Is Z-DNA found in all organisms?

Z-DNA-forming sequences and Z-DNA-binding proteins are found in a wide range of organisms, from bacteria to humans. However, the abundance and functional significance of Z-DNA vary. In bacteria, Z-DNA has been implicated in transcription regulation, while in mammals, it also plays a role in innate immunity.

### Does Z-DNA cause disease?

Z-DNA has been associated with disease, particularly cancer and autoimmune diseases. In cancer, Z-DNA formation at oncogene promoters can promote genomic instability and altered gene expression. In autoimmune diseases, anti-Z-DNA antibodies are found in patients with SLE and may contribute to pathology. However, Z-DNA also has normal functions, and disease arises from dysregulation.

### Why is Z-DNA left-handed?

Z-DNA is left-handed because of the alternating sugar pucker conformations and glycosidic bond orientations of its nucleotides. Purines adopt the syn conformation, while pyrimidines adopt the anti conformation, causing the backbone to zigzag and the helix to twist in a left-handed direction. This is in contrast to B-DNA, where all nucleotides adopt the anti conformation and the helix is right-handed.

## Key Takeaways

- Z-DNA is a left-handed double helix with a zigzag backbone, distinct from the right-handed B-DNA.
- Z-DNA forms preferentially at alternating purine-pyrimidine sequences and is stabilized by negative supercoiling, high salt, and cytosine methylation.
- Z-DNA is found in promoters, enhancers, and transcriptionally active regions, where it regulates gene expression.
- Z-DNA-binding proteins, including ADAR1 and ZBP1, mediate its biological functions in RNA editing and innate immunity.
- Z-DNA is detected using specific antibodies, circular dichroism spectroscopy, and chemical footprinting.
- Z-DNA is implicated in cancer and autoimmune diseases, making it a potential therapeutic target.
- Z-DNA is a dynamic, transient structure that plays both normal and pathological roles in biology.

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)